Why is Unichem Laboratories Ltd falling/rising?

Recent Price Movement and Market Performance

Unichem Laboratories has been under pressure in the short term, with the stock falling 6.37% over the past week compared to a 2.55% decline in the Sensex. Over the last month, the stock has declined 6.61%, significantly underperforming the benchmark index's 1.29% loss. Year-to-date, the stock is down 5.97%, while the Sensex has fallen by a lesser 1.93%. The most striking figure is the one-year return, where Unichem Laboratories has plummeted 40.71%, in stark contrast to the Sensex's 7.67% gain. This underperformance extends to the medium term as well, with the stock barely keeping pace with the Sensex over three years, posting a 37.83% gain versus the benchmark's 37.58%, and lagging over five years with a 47.82% rise compared to the Sensex's 71.32%.

On 09-Jan, the stock hit a new 52-week low of ₹410.6, marking a fresh nadir for investors. The share price has been declining for two consecutive days, losing 4.7% in that period. Intraday, the stock touched a low of ₹410.6, down 3.24%. Furthermore, Unichem Laboratories is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating a sustained bearish trend. Despite this, investor participation has increased, with delivery volumes on 08 Jan rising by 92.19% compared to the five-day average, suggesting heightened trading activity amid the decline.

Fundamental Strengths Amidst Weakness

Despite the recent price weakness, Unichem Laboratories exhibits some positive fundamental attributes. The company has demonstrated healthy long-term operating profit growth, expanding at an annual rate of 37.55%. Its return on capital employed (ROCE) stands at 4.9%, which, coupled with an enterprise value to capital employed ratio of 1.2, suggests a very attractive valuation relative to its peers. The stock is trading at a discount compared to the average historical valuations of comparable companies. Notably, while the stock has delivered a negative return of 40.71% over the past year, the company’s profits have surged by an impressive 419.9%, resulting in a low price/earnings to growth (PEG) ratio of 0.1. The majority shareholding remains with promoters, indicating stable ownership.

Challenges Weighing on the Stock

However, these positives are overshadowed by significant concerns that have contributed to the stock’s decline. The company’s ability to service its debt is limited, as evidenced by a high Debt to EBITDA ratio of 4.87 times. This elevated leverage raises questions about financial flexibility and risk. Additionally, the company’s net sales growth has been modest, at an annual rate of 12.60% over the last five years, reflecting subdued top-line expansion. Return on equity (ROE) averages a low 1.44%, indicating limited profitability generated from shareholders’ funds.

Recent quarterly results have been flat, with a debt-to-equity ratio at 0.21 times and interest expenses reaching ₹8.24 crores. Non-operating income constitutes 44.20% of profit before tax, suggesting reliance on income sources outside core operations. The stock’s underperformance is not limited to the short term; it has lagged the BSE500 index over the last three years, one year, and three months, signalling persistent challenges in delivering shareholder value.

Conclusion: Why the Stock Is Falling

In summary, Unichem Laboratories Ltd’s share price decline on 09-Jan and over recent periods is primarily driven by its weak financial performance, high leverage, and underwhelming returns to shareholders. While the company shows promising profit growth and attractive valuation metrics, these are offset by concerns over debt servicing capacity, flat recent results, and sustained underperformance relative to market benchmarks. The stock’s breach of key moving averages and new 52-week lows further reinforce the bearish sentiment among investors. Until the company can demonstrate stronger sales growth, improved profitability, and better debt management, the downward pressure on its share price is likely to persist.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →